Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 815 results for "Treatment For Ovarian Cancer"

Roche receives FDA approval for ovarian cancer drug

Roche has received the FDA approval for Avastin in combination with chemotherapy for the treatment of women with platinum-resistant, recurrent ovarian cancer. The approval was based on results from the Phase III AURELIA study that showed Avastin ..., 1 day ago

18 images for Treatment For Ovarian Cancer

Florida Times-Union, 3 days ago
Miami Herald, 1 week ago
MedIndia, 1 month ago
Med India, 1 day ago
ALN, 1 day ago
OncLive, 1 week ago
Pharmaceutical Journal, 3 weeks ago
Drug Discovery and Development, 5 days ago
Citybizlist, 6 days ago
MyScience, 1 month ago
Med India

FDA Approves a New Indication for Avastin

Genentech's cancer drug Avastin won approval to treat platinum-resistant, recurrent ovarian cancer in combination with chemotherapy, marking the eighth time the FDA has approved an indication on the blockbuster product. The latest approval for ...
 FDA News2 days ago Genentech receives FDA approval for treatment of ovarian cancer  Individual.com4 days ago Roche : Gets U.S. Approval for Avastin Treatment of Ovarian Cancer  4 Traders6 days ago Roche Gets U.S. Approval for Avastin Treatment of Ovarian...  ADVFN India6 days ago

Ovarian Cancer may be Treatable With Anti-Leukemia Drug

Researchers at the University of California, San Diego School of Medicine, report that an antibody therapy already in clinical trials to treat Chronic Lymphocytic Leukaemia (CLL) may also be used to treat ovarian cancer and likely other cancers as ...
 MedIndia4 days ago Anti-leukemia drug may also work against ovarian cancer  Science Daily1 day ago
Reuters India

Roche says Avastin approved in US

Roche said on Monday that the US health regulator approved its Avastin drug as a treatment for women with ovarian cancer that is resistant to platinum-containing chemotherapy. Avastin, which is already approved in Europe to treat advanced stages of ...
 Hindu Business Line5 days ago Roche says Avastin approved in U.S. for type of ovarian cancer  Reuters6 days ago

Antiangiogenic Treatment, Chemotherapy Improves Survival in Ovarian Cancer Model

Epithelial ovarian cancer is the most lethal cancer of the female reproductive organs, with more than 200,000 new cases and more than 125,000 deaths each year worldwide. Because symptoms tend to be vague, 80 percent of these cancers are not ...
 ALN1 day ago New combination therapy improves survival in patients with advanced ovarian cancer  News-Medical.Net2 days ago Antiangiogenic treatment improves survival in animal model of ovarian cancer  EurekAlert!2 days ago Animal Study Finds Antiangiogenic Treatment Improves Survival in Ovarian Cancer  MedIndia1 day ago

Patent Issued for Antibodies against CDCP1 for the Treatment of Cancer

By a News Reporter-Staff News Editor at Cancer Weekly -- According to news reporting originating from Alexandria, Virginia , by NewsRx journalists, a patent by the inventors Bossenmaier, Birgit (Seefeld, DE); Fertig, Georg (Penzberg, DE); Krell, ...
 4 Traders3 days ago Patent Issued for Compositions and Methods for Treatment of Ovarian Cancer  4 Traders3 days ago Researchers Submit Patent Application, "B7-H1 and Survivin in Cancer", for Approval  4 Traders3 days ago

Cancer-killing virus plus chemotherapy drug might treat recurrent ovarian cancer

In six out of 10 cases, ovarian cancer is diagnosed when the disease is advanced and five-year survival is only 27 percent. A new study suggests that a cancer-killing virus combined with a chemotherapy drug might safely and effectively treat ...
 Science Daily4 days ago Recurrent ovarian cancer treatment combo of cancer-killing virus plus chemotherapy  Medical News Today5 days ago "Cancer-Killing Virus Plus Chemotherapy Drug Might Treat Recurrent Ovarian Cancer," The Ohio State University Comprehensive Cancer Center James Cancer Hospital and Solove Research Institute  NCCN.com3 days ago
University of Queensland

Diet may influence ovarian cancer survival

Women with healthier diets before an ovarian cancer diagnosis are less likely to die than women with poorer diets, according to study. The exceptions were women with diabetes or a high waist circumference, which is often linked to diabetes. A ... day ago Clinical trial to target ovarian and breast cancers  University of Queensland4 days ago

Pfizer, Merck KGaA Strike A $2.9B Deal To Develop Cancer Tumor Treatment

November 17, 2014 By Mark Terry , Breaking News Staff Pfizer Inc. ( PFE ), and Merck KGaA , headquartered in Darmstadt, Germany, jointly announced today that the two companies had entered into a global development deal for an ...
 BioSpace5 days ago Merck partners with Pfizer to co-develop and co-commercialize anti-cancer drug  Individual.com1 day ago Pfizer signs $3 billion cancer deal  Pharmafocus4 days ago Merck KGaA, Pfizer Launch Up-to-$2.85B Cancer Immunotherapy Alliance  Genetic Engineering News5 days ago

Polaris Group Announces Treatment of First Patient in Phase 1 Study of ADI-PEG

20 plus Doxorubicin in HER2 Negative Breast Cancer 11/18 12:30 CST 20 plus Doxorubicin in HER2 Negative Breast Cancer SAN DIEGO, Nov. 18, 2014 SAN DIEGO, Nov. 18, 2014 /PRNewswire/ -- Polaris Group announced today that the first patient has ...
 Finwin4 days ago Celsion Announces Enrollment of First Patient in Global Phase III OPTIMA Study of ThermoDox┬« in Primary Liver Cancer  AndhraNews.net1 day ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less